Stock listing

Alvotech

Selected listing: ALVOUSD · BX · USD · CH

Alvotech (BX Swiss: ALVOUSD), Health Technology. Latest release Oct 5, 2026: FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s…

ALVOUSD:BXUSDCHUpdated October 2, 2026

Ticker: BX Swiss: ALVOUSD
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BX Swiss
Currency: USD

Latest news from Alvotech

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

October 4, 2026

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

October 4, 2026

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

October 5, 2026

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

August 31, 2026

Alvotech to present at upcoming investor conferences in September

August 27, 2026

All Alvotech news →

Events

Replays

Alvotech (ALVO) Q2 2026 Earnings Call
Thu, Aug 20, 2026 · 08:00 AM ET
Watch
Alvotech (ALVO) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Alvotech (ALVO) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 08:00 AM ET
Watch

Research Alvotech

Alvotech company profile

View the public company page for Alvotech on 6ix.

Alvotech news

Read company news and market updates connected to Alvotech.

Alvotech investor events

Find investor webinars, events, and replay context for Alvotech.